Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes

Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes

Multidrug resistant (MDR) and extensively drug resistant tuberculosis (TB) are a threat to the TB control programs in developing countries, and the situation is worsened by the human immunodeficiency virus (HIV) pandemic. This study was performed to correlate treatment outcome with the resistance pa...

Full description

Bibliographic Details
Main Authors: C.K. Vidyaraj, A. Chitra, S. Smita, M. Muthuraj, S. Govindarajan, B. Usharani, S. Anbazhagi
Format: Article
Language:English
Published: Springer 2019-04-01
Series:Journal of Epidemiology and Global Health
Online Access:https://www.atlantis-press.com/article/125905839/view

Similar Items

Similar Items